Acrivon Therapeutics(ACRV) - 2025 Q4 - Annual Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 08, 2026 480 Arsenal Way Suite 100 Watertown, Massachusetts 02472 (Address of Principal Executive Offices) (Zip Code) Delaware 001-41551 82-5125532 (Commission File Number) (IRS Employer Identification No.) Registrant's Telephone Number, Including Area Code: (617) 207-8979 Acrivon Thera ...